Chemical industry – Page 82
-
NewsPrivatisation fears for UK environment body
Union warns research may be sidelined by commercial interests at the Food and Environment Research Agency
-
Business
Lilly protests $450m Brazilian fine
Firm says chemicals employees were allegedly exposed to were never used at site
-
Business
Chinese police hand GSK bribery case to prosecutors
Investigation alleges senior manager ordered staff to hand out bribes
-
BusinessPfizer presses hard for AstraZeneca deal
Executives face down international controversy over tax schemes and previous post-merger record
-
NewsPledge to create 2000 new STEM posts
UK government teams up with industry as part of campaign to inspire young people to take up science and engineering
-
Business
Solvay-Ineos PVC deal passes European approval
Firms required to divest plants to maintain competition
-
BusinessBayer wins race to buy Merck & Co consumer care
$14bn deal will make Aspirin inventor the number two over-the-counter healthcare company
-
Business
UK Lords urge government to take lead on fracking
Regulations holding back shale gas exploration, report says
-
CareersScience within Reach
Charlotte Ashley-Roberts explains what the Reach regulations could mean for you and your role
-
Business
UK regulator warning over online herbal remedies
Products found to contain toxic metals or undeclared prescription-only drugs
-
Business
Insider trading allegations stall Sun–Ranbaxy deal
Companies deny wrongdoing in lead-up to merger announcement
-
Business
Forest Labs buys Furiex for bowel drug
Firm will immediately sell on other assets to Royalty Pharma
-
Business
BASF to cut 260 jobs in nutrition and health
Firm to sell Norwegian site and shift focus towards Asia
-
OpinionEngineering serendipity
It takes more than random stumbling to find new reactions, says Derek Lowe
-
OpinionFrack and blue
Shale gas will do little to improve the competitiveness of Europe’s chemical industry, argues Mark Peplow
-
Business
Generics triumph in anti-inflammatory patent battle
Pfizer settles deals to allow copycat celecoxib
-
Business$25bn-plus trade sharpens pharma giants’ focus
Novartis’ asset swaps with GSK and Eli Lilly are the latest steps in an ongoing streamlining process
-
Business
GSK corruption investigation widens
BBC investigation airs allegations of misconduct in Poland